Afqlir 40 mg/ml
Afqlir 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 70127. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 September 2025 and the authorisation is limited until 24 September 2030. ATC code S01LA05 places the medicine in the group Ophthalmologicals.
| Authorisation number | 70127 |
|---|---|
| Name | Afqlir 40 mg/ml |
| Full name | Afqlir 40 mg/ml, Injektionslösung |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01LA05 |
| First authorisation | 25 September 2025 |
| Authorisation validity | 24 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Afqlir 40 mg/ml, Injektionslösung | B | 25 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | S01LA05 | 11.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Afqlir 40 mg/ml authorised in Switzerland?
Yes. Afqlir 40 mg/ml is authorised by Swissmedic under authorisation number 70127, data as of 01 September 2026. The authorisation is limited until 24 September 2030.
Which dispensing category does Afqlir 40 mg/ml have?
Afqlir 40 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Afqlir 40 mg/ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.